Physician profile
Daniel T Weber
NPI 1316051956
$32,683.39
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,337 · 2020: $2,751 · 2021: $186 · 2022: $12K · 2023: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,500 · Travel and Lodging: $1,110 · Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,500.00 |
| Travel and Lodging | $1,110.13 |
| Food and Beverage | $380.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $23,110.41 | 2021-2023 | Djo Surgical |
| Stryker Corporation | $6,742.35 | 2019-2021 | |
| Arthrex, INC. | $1,461.50 | 2019 | |
| Medwest Associates | $898.00 | 2019 | |
| Intellijoint Surgical INC. | $211.77 | 2022 | |
| Microport Orthopedics INC | $146.18 | 2022 | |
| Zimmer Biomet Holdings, INC. | $52.37 | 2023 | Sternalock Blu System |
| Si-Bone, INC. | $25.45 | 2019 | |
| Depuy Synthes Sales INC. | $17.66 | 2022 | |
| Medtronic USA, INC. | $13.24 | 2019 | |
| Fidia Pharma USA INC. | $4.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.